Evnin; Luke
Patent Applications and Registrations
Patent applications and USPTO patent grants for Evnin; Luke.The latest application filed is for "separation moieties and methods of use thereof".
Company Profile
22.17.30
- Evnin; Luke - San Francisco CA
- Evnin; Luke - Cambridge MA
Patent Activity
| Patent | Date |
|---|---|
| Activatable interleukin 12 polypeptides and methods of use thereof Grant 11,453,710 - Winston , et al. September 27, 2 | 2022-09-27 |
| Single domain serum albumin binding protein Grant 11,453,716 - Dubridge , et al. September 27, 2 | 2022-09-27 |
| Separation Moieties And Methods Of Use Thereof App 20220220181 - WINSTON; William ; et al. | 2022-07-14 |
| Activatable interleukin-2 polypeptides and methods of use thereof Grant 11,352,403 - Winston , et al. June 7, 2 | 2022-06-07 |
| Activatable Interleukin-2 Polypeptides And Methods Of Use Thereof App 20220056096 - WINSTON; William ; et al. | 2022-02-24 |
| Activatable Interleukin-2 Polypeptides And Methods Of Use Thereof App 20210403524 - WINSTON; William ; et al. | 2021-12-30 |
| Oncolytic viral delivery of therapeutic polypeptides Grant 11,078,280 - Evnin , et al. August 3, 2 | 2021-08-03 |
| Trispecific Binding Proteins And Methods Of Use App 20210179735 - BAEUERLE; Patrick ; et al. | 2021-06-17 |
| Separation Moieties And Methods Of Use Thereof App 20210115102 - WINSTON; William ; et al. | 2021-04-22 |
| Oncolytic Viral Delivery Of Therapeutic Polypeptides App 20210085735 - FINER; Mitchell H. ; et al. | 2021-03-25 |
| Trispecific binding proteins and methods of use Grant 10,954,311 - Baeuerle , et al. March 23, 2 | 2021-03-23 |
| Methods of Using Bispecific CD33 and CD3 Binding Proteins App 20210032339 - Evnin; Luke ; et al. | 2021-02-04 |
| Bispecific CD33 and CD3 Binding Proteins App 20210024654 - Ellwanger; Kristina ; et al. | 2021-01-28 |
| Activatable Interleukin 12 Polypeptides And Methods Of Use Thereof App 20200283489 - Winston; William ; et al. | 2020-09-10 |
| Activatable Interleukin-2 Polypeptides And Methods Of Use Thereof App 20200283490 - Winston; William ; et al. | 2020-09-10 |
| Methods of using bispecific CD33 and CD3 binding proteins Grant 10,738,118 - Evnin , et al. A | 2020-08-11 |
| Single Chain Variable Fragment Cd3 Binding Proteins App 20200231672 - DUBRIDGE; Robert B. ; et al. | 2020-07-23 |
| Activatable interleukin-2 polypeptides Grant 10,696,724 - Winston , et al. June 30, 2 | 2020-06-30 |
| Activatable interleukin 12 polypeptides Grant 10,696,723 - Winston , et al. June 30, 2 | 2020-06-30 |
| Oncolytic Viral Delivery Of Therapeutic Polypeptides App 20200157221 - EVNIN; Luke | 2020-05-21 |
| Bispecific CD33 and CD3 binding proteins Grant 10,626,190 - Ellwanger , et al. | 2020-04-21 |
| Compositions And Methods For Adoptive Cell Therapies App 20200115461 - EVNIN; Luke ; et al. | 2020-04-16 |
| Oncolytic viral delivery of therapeutic polypeptides Grant 10,604,574 - Evnin | 2020-03-31 |
| Activatable Interleukin-2 Polypeptides And Methods Of Use Thereof App 20200040052 - WINSTON; William ; et al. | 2020-02-06 |
| Single chain variable fragment CD3 binding proteins Grant 10,544,221 - Dubridge , et al. Ja | 2020-01-28 |
| Activatable Interleukin 12 Polypeptides And Methods Of Use Thereof App 20190367576 - WINSTON; William ; et al. | 2019-12-05 |
| Innate Immune Cell Trispecific Binding Proteins And Methods Of Use App 20190225702 - BAEUERLE; Patrick ; et al. | 2019-07-25 |
| Pseudotyped Oncolytic Viral Delivery Of Therapeutic Polypeptides App 20190048082 - Evnin; Luke | 2019-02-14 |
| Single Domain Serum Albumin Binding Protein App 20190031749 - DUBRIDGE; Robert B. ; et al. | 2019-01-31 |
| Single domain serum albumin binding protein Grant 10,100,106 - Dubridge , et al. October 16, 2 | 2018-10-16 |
| Bispecific CD33 and CD3 Binding Proteins App 20180291113 - ELLWANGER; Kristina ; et al. | 2018-10-11 |
| Single chain variable fragment CD3 binding proteins Grant 10,066,016 - Dubridge , et al. September 4, 2 | 2018-09-04 |
| Methods Of Using Bispecific Cd33 And Cd3 Binding Proteins App 20180148507 - EVNIN; Luke ; et al. | 2018-05-31 |
| Inducible Binding Proteins And Methods Of Use App 20180134789 - BAEUERLE; Patrick ; et al. | 2018-05-17 |
| Single domain serum albumin binding protein Grant 9,920,115 - Dubridge , et al. March 20, 2 | 2018-03-20 |
| Pseudotyped Oncolytic Viral Delivery Of Therapeutic Polypeptides App 20180057594 - EVNIN; Luke | 2018-03-01 |
| Single Chain Variable Fragment Cd3 Binding Proteins App 20170369575 - DUBRIDGE; Robert B. ; et al. | 2017-12-28 |
| Single Domain Serum Albumin Binding Protein App 20170369563 - DUBRIDGE; Robert B. ; et al. | 2017-12-28 |
| Single Domain Serum Albumin Binding Protein App 20170334979 - DUBRIDGE; Robert B. ; et al. | 2017-11-23 |
| Single Chain Variable Fragment Cd3 Binding Proteins App 20170334997 - DUBRIDGE; Robert B. ; et al. | 2017-11-23 |
| Bispecific CD33 and CD3 binding proteins Grant 9,803,029 - Ellwanger , et al. October 31, 2 | 2017-10-31 |
| Trispecific Binding Proteins And Methods Of Use App 20170298149 - BAEUERLE; Patrick ; et al. | 2017-10-19 |
| Trispecific binding proteins and methods of use Grant 9,708,412 - Baeuerle , et al. July 18, 2 | 2017-07-18 |
| Trispecific Binding Proteins And Methods Of Use App 20160340444 - BAEUERLE; Patrick ; et al. | 2016-11-24 |
| Bispecific CD33 and CD3 Binding Proteins App 20160194409 - ELLWANGER; Kristina ; et al. | 2016-07-07 |
| Bispecific CD33 and CD3 Binding Proteins App 20160002333 - ELLWANGER; Kristina ; et al. | 2016-01-07 |
| Bispecific CD33 and CD3 binding proteins Grant 9,212,225 - Ellwanger , et al. December 15, 2 | 2015-12-15 |
Company Registrations
| SEC | 0001134657 | EVNIN LUKE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 